Asia-Pacific Biologics CMO Facilities

Access in-depth research and analysis of Contract Manufacturing (CMOs) providers for the Biologics industry in Asia. The 150 page report covers key biologics Contract Manufacturing companies from Asian markets such as China, Korea, Japan, Southeast Asia, and India are covered, featuring extensive information: years of operation, types of bioreactors used, manufacturing capacity, types of products, financial performance, current clients, and future expansion plans.

 

Report Snapshot

Featured Companies

PURCHASE YOUR REPORT HERE!

For offline payments or inquiries, kindly contact Aisyah Atiqah at

e: aisyah.atiqah@imapac.com

t: +65 3109 0158

This license grants the right of use of the purchased report to a single recipient only. You may access the material on your computer, as and when required, for your own personal use.

Upto 3 users: This license grants the right of use of the purchased report by upto 3 users.

Unlimited user access (Within your organization): This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the number of users.

Section 1
• Preface
• Report Scope & Data Coverage
• IMAPAC’s Research Methodology

Section 2: Company-Wise Data & Analysis
• Company Overview
• Manufacturing Sites
• Facility Design
• Plant Capacity
• Batch Size
• GMP Certification
• Products Manufactured
• Manufacturing Services
• Projects
• Partnerships & Collaborations
• Capacity Planning & Future Expansion
• Interview
• Industry News & Updates
• Swot Analysis
• References

Section 3: Region-Wise Data & Analysis of CMO’s {Regions Covered: China, Taiwan, Japan & Korea, India, Australia & Sea}
• Products manufactured: vaccines| cell therapy| recombinant proteins & mabs | others
• Technologies housed & manufacturing services
• Production lines
• GMP certification
• Facility size, design and capacity planning
• Team size & distribution
• PESTEL analysis

Section 4: Our Other Reports
• Bibiliography
• Disclaimer
• About Us
• Our Other Reports

• Amaran Biotechnology
• Boehringer Ingelheim
• Cmab Biopharma
• Cellular Biomedicine Group
• Cp Goujian Pharma
• Eirgenix
• Innovent Biologics
• Jade Biomedical
• Jhl Biotech
• Joinn Biologics
• Lonza China
• Mycenax Biotech
• Obio Technology
• Orient Pharma
• Sinobioway
• Taron Solutions
• United Biopharma
• Wuxi Apptec
• Clonz Biotech
• Intas Pharmaceuticals
• Kemwell Biopharma
• Stelis Biosource
• Syngene
• Zumotor Biologics
• Mesoblast
• Pfizer Centreone
• Luina Bio
• Biocon
• Esco Aster
• Inno Biologics
• Lonza Ag Singapore
• Cellworx
• Anterogen
• Binex
• Celltrion
• Eubiologics
• Kolon Life Sciences
• Masthercell
• Samsung Biologics
• SK Corp
• Agc Biologics
• Ajinomoto Bio- Pharma
• Bushu Pharmaceuticals
• Hitachi Chemical
• Id Pharma
• Medinet
• Pharmabio
• Takara Bio
• Toyobo

Other Market Research